Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Krystal Biotech is a biotechnology company specializing in gene therapies for rare and serious diseases. Using its proprietary HSV-1 platform, it develops and commercializes treatments like VYJUVEK for dystrophic epidermolysis bullosa and pipeline candidates for ophthalmology, respiratory, oncology, and dermatology. The company focuses on non-invasive, repeatable gene delivery to address high unmet medical needs globally.
This description was generated via AI from an annual report. Updated about 1 year ago.